(Q42257672)

19 October 2017

Chemoprevention of age-related macular regeneration (AMD) with rapamycin (English)

1 reference

19 October 2017

X F Steven Zheng

1

1 reference

19 October 2017

1 June 2012

1 reference

19 October 2017

1 reference

19 October 2017

4

1 reference

19 October 2017

6

1 reference

19 October 2017

375-376

1 reference

Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409673

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409673

Ranibizumab for neovascular age-related macular degeneration

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409673

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409673

Systemic rapamycin inhibits retinal and choroidal neovascularization in mice

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409673

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409673

Age-related macular degeneration

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22796653

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/AGING.100469

0 references

PMC publication ID

3409673

1 reference

PMC publication ID

3409673

19 October 2017

PubMed publication ID

22796653

1 reference

PMC publication ID

3409673